Search research articles
Contact Us
Filters
Showing results (441-450 of 451) with videos related to
Page
of 46
Sort By:
Leukemia
|
January 23, 2024
The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification
K Nachtkamp, C Strupp, M Vukelja, et al.
Neurobiology of Aging
|
February 5, 2021
Dissecting the role of Amerindian genetic ancestry and the ApoE ε4 allele on Alzheimer disease in an admixed Peruvian population
Maria Victoria Marca-Ysabel, Farid Rajabli, Mario Cornejo-Olivas, et al.
Leukemia
|
May 7, 2014
Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib
B Hanfstein, V Shlyakhto, M Lauseker, et al.
Leukemia
|
May 3, 2016
Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS)
M Mossner, J-C Jann, D Nowak, et al.
Leukemia
|
February 1, 2012
Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): a multicenter study
U Germing, M Lauseker, B Hildebrandt, et al.
Leukemia
|
June 18, 2026
Comprehensive molecular characterization of treatment-free remission and molecular relapse in chronic myeloid leukemia patients: the EURO-SKI Biomarker Study
S Rinaldetti, M Chepeleva, A Hedblom, et al.
Leukemia
|
February 10, 2016
Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV
M B Miranda, M Lauseker, M-P Kraus, et al.
Leukemia
|
March 27, 2012
Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)
B Hanfstein, M C Müller, R Hehlmann, et al.
Neurobiology of Aging
|
April 27, 2021
Linkage of Alzheimer disease families with Puerto Rican ancestry identifies a chromosome 9 locus
Farid Rajabli, Briseida E Feliciano-Astacio, Holly N Cukier, et al.
Leukemia
|
April 12, 2016
Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia
V Madan, P Shyamsunder, L Han, et al.
Page
of 46
Search research articles
Search
Showing results (441-450 of 451) with videos related to
Sort By:
Page
of 46
Leukemia
|
January 23, 2024
The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification
K Nachtkamp, C Strupp, M Vukelja, et al.
Neurobiology of Aging
|
February 5, 2021
Dissecting the role of Amerindian genetic ancestry and the ApoE ε4 allele on Alzheimer disease in an admixed Peruvian population
Maria Victoria Marca-Ysabel, Farid Rajabli, Mario Cornejo-Olivas, et al.
Leukemia
|
May 7, 2014
Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib
B Hanfstein, V Shlyakhto, M Lauseker, et al.
Leukemia
|
May 3, 2016
Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS)
M Mossner, J-C Jann, D Nowak, et al.
Leukemia
|
February 1, 2012
Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): a multicenter study
U Germing, M Lauseker, B Hildebrandt, et al.
Leukemia
|
June 18, 2026
Comprehensive molecular characterization of treatment-free remission and molecular relapse in chronic myeloid leukemia patients: the EURO-SKI Biomarker Study
S Rinaldetti, M Chepeleva, A Hedblom, et al.
Leukemia
|
February 10, 2016
Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV
M B Miranda, M Lauseker, M-P Kraus, et al.
Leukemia
|
March 27, 2012
Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)
B Hanfstein, M C Müller, R Hehlmann, et al.
Neurobiology of Aging
|
April 27, 2021
Linkage of Alzheimer disease families with Puerto Rican ancestry identifies a chromosome 9 locus
Farid Rajabli, Briseida E Feliciano-Astacio, Holly N Cukier, et al.
Leukemia
|
April 12, 2016
Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia
V Madan, P Shyamsunder, L Han, et al.
Page
of 46